Can eye scans and herbal medicine fix diabetes brain damage?

NCT ID NCT06813274

Not yet recruiting Knowledge-focused Sponsor: Hejiang Ye Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how diabetes affects small blood vessels and nerves in the eyes and brain. Researchers will use advanced imaging to detect damage and test a traditional Chinese herbal medicine called Tangshen'an Granules to see if it can help. 160 adults with diabetes will take either the herbal granules or a placebo for a set time, while doctors monitor their vision, brain structure, and thinking skills. The goal is to find better ways to diagnose and treat these complications early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Tangshen'an Granules (a blend of herbs) and Ginkgo Leaf Tablets

What this could lead to

If successful, this could provide a new way to diagnose and treat nerve and blood vessel damage in diabetes using eye and brain scans, and support the use of a traditional Chinese medicine.

What could go wrong

This is an early Phase 2 trial with only 160 participants, so results may not apply to everyone. The herbal treatment may not work better than placebo, and side effects are not yet fully known.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction diabetes mellitus diabetic retinopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Deyang Hospital Affiliated to Chengdu University of Traditional Chinese Medicine

    Deyang, Sichuan, 618000, China

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Guangyuan North Sichuan Diabetes Specialty Hospital

    Guangyuan, Sichuan, 628000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Hospital of Chengdu University of Traditional Chinese Medicine

    Chengdu, Sichuan, 610072, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact